N-Ethylhexedrone

N-Ethylhexedrone (also known as Hexen and NEH) is a stimulant compound of the cathinone class. Cathinones are a sub-category of amphetamines, sharing the core amphetamine structure of a phenyl ring bound to an amino (NH2) group through an ethyl chain and an additional methyl substitution at Rα.

N-Ethylhexedrone was first mentioned in a series of patents by Boehringer Ingelheim in the 1960s which led to the development of the better-known drug methylenedioxypyrovalerone (MDPV). Since the mid-2010s, N-ethylhexedrone has been sold online as a designer drug and is often used for recreational purposes.

Effects

The effects of N-Ethylhexedrone have been described by users as having a moderate to high stimulant effect, similar to the effects of methamphetamine. It is often associated with a high level of euphoria, increased energy, elevated mood, and increased sociability. However, it can also cause negative effects such as anxiety, paranoia, and increased heart rate.

Legal Status

The legal status of N-Ethylhexedrone varies by country. In the United States, it is not regulated under the Controlled Substances Act, but it is listed as a Schedule I substance in Florida. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act.

Health Risks

As with other stimulants, the use of N-Ethylhexedrone can lead to intense cravings and compulsive drug-taking behavior. The drug can also cause a range of health problems, including heart disease, psychosis, and severe neurological damage. It is highly advised to use harm reduction practices if using this substance.

See Also

• Cathinone
• Stimulant
• Designer drug
• Boehringer Ingelheim
• Methylenedioxypyrovalerone

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

• 
•